Skip to main content

empagliflozin (Jardiance®)

 

Status: Excluded due to NICE appraisal

Product meets AWMSG exclusion criteria due to NICE appraisal TA773: Empagliflozin for treating chronic heart failure with reduced ejection fraction

Medicine details

Medicine name empagliflozin (Jardiance®)
Formulation 10mg, 25mg film coated tablets
Reference number 3597
Indication

Treatment of symptomatic chronic heart failure with reduced ejection fraction

Company Boehringer Ingelheim Ltd
BNF chapter Cardiovascular system
Assessment type N/A
Status Excluded due to NICE appraisal
Date of issue 22/06/2021
NICE guidance

TA773: Empagliflozin for treating chronic heart failure with reduced ejection fraction

Follow AWTTC: